These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8013973)

  • 21. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies for optimizing the collection of blood components in a multiple bag system].
    Taborski U; Müller N
    Beitr Infusionsther; 1988; 21():87-90. PubMed ID: 2463021
    [No Abstract]   [Full Text] [Related]  

  • 23. Transient transforming growth factor β1 modulation in monocytes and natural killer cells following plasma or plasma-platelet apheresis donation procedures.
    Ghio M; Contini P; Ubezio G; Ansaldi F; Setti M; Tripodi G
    Blood Transfus; 2015 Oct; 13(4):684-6. PubMed ID: 25761316
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanical plasmapheresis by means of the Haemonetics-ultralite- plasma collection system: 2. Generation of platelet-rich plasma].
    Richter E; Pawlow I; Matthes G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):127-33. PubMed ID: 1695166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical review of platelet yield by Haemonetics 30 . Based on literature and own observations.
    Rosenkvist J; Holsøe E; Freiesleben E; Sørensen H
    Scand J Haematol; 1980 Aug; 25(2):165-70. PubMed ID: 7466305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Statistical analysis of parameters which determine yield in continuous centrifugal plateletpheresis].
    Hühn A; Sachs V; Dörner R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):277-81. PubMed ID: 2475408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling of platelet concentrate yield in continuous-flow cell separation devices.
    Hester JP; Ventura GJ
    J Clin Apher; 1988; 4(4):188-93. PubMed ID: 3220820
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
    Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
    J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the platelet concentrate obtained with the MCS cell separator of the Society of Haemonetics].
    Schooneman F
    Ann Med Interne (Paris); 1994; 145(5):345-9. PubMed ID: 7985946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated platelet production during plasmapheresis.
    Rock G; Herzig R; McCombie N; Lazarus HM; Tittley P
    Transfusion; 1983; 23(4):290-3. PubMed ID: 6879667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of three different preparations of platelet concentrates for growth factor enrichment.
    Appel TR; Pötzsch B; Müller J; von Lindern JJ; Bergé SJ; Reich RH
    Clin Oral Implants Res; 2002 Oct; 13(5):522-8. PubMed ID: 12453130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plateletpheresis using the haemonetics model 30 cell separator.
    Nusbacher J; Scher ML; MacPherson JL
    Vox Sang; 1977 Jul; 33(1):9-15. PubMed ID: 883246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood component collection by apheresis.
    Burgstaler EA
    J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-donor platelet apheresis: observational comparison of the new Haemonetics Universal Platelet protocol with the previous Concentrated Single Donor Platelet protocol.
    Salvadori U; Minelli C; Graziotin B; Gentilini I
    Blood Transfus; 2014 Apr; 12(2):220-5. PubMed ID: 24333087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of concurrent collection of plasma into a plateletpheresis program.
    Burger SR; Thomas BT; Grishaber JE
    J Clin Apher; 1994; 9(2):126-9. PubMed ID: 7798160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.